These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 14152073)
1. THE PHYSICIAN AS FINAL ARBITER? PAGE I Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073 [No Abstract] [Full Text] [Related]
2. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA. WESTON JK; WESTON K Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685 [No Abstract] [Full Text] [Related]
3. AN INTERNATIONAL DRUG SAFEGUARD PLAN. FINNEY DJ J Chronic Dis; 1964 Jul; 17():565-81. PubMed ID: 14179659 [No Abstract] [Full Text] [Related]
4. PHYSICIAN'S LIABILITY WHEN USING NEW OR EXPERIMENTAL DRUGS. WASMUTH CE Cleve Clin Q; 1964 Apr; 31():61-73. PubMed ID: 14141716 [No Abstract] [Full Text] [Related]
5. HOW THE FOOD AND DRUG ADMINISTRATION EVALUATES NEW DRUG APPLICATIONS. LARRICK GP J New Drugs; 1964; 4(2):63-74. PubMed ID: 14197105 [No Abstract] [Full Text] [Related]
6. NEW DRUG SURVEILLANCE IN 1964. ELLENHORN MJ Am J Pharm Sci Support Public Health; 1964; 136():114-27. PubMed ID: 14167236 [No Abstract] [Full Text] [Related]
7. [ANIMAL AND HUMAN EXPERIMENTATION WITH NEW DRUGS]. MARCONI M; DOMINICI A Clin Ter; 1964 Jun; 29():562-81. PubMed ID: 14184056 [No Abstract] [Full Text] [Related]
8. THE PHYSICIAN AND THE FOOD AND DRUG ADMINISTRATION. SADUSK JF JAMA; 1964 Dec; 190():907-9. PubMed ID: 14214493 [No Abstract] [Full Text] [Related]
9. WASHINGTON AND NEW DRUGS. NEW REGULATIONS REQUIRE FILING OF SAFETY AND EFFICACY DATA FOR NEW DRUGS INTRODUCED SINCE 1938. LARRICK GP J New Drugs; 1964; 4(2):105-10. PubMed ID: 14197104 [No Abstract] [Full Text] [Related]
10. USE AND ABUSE OF DRUGS. DUNLOP D Br Med J; 1965 Aug; 2(5459):437-41. PubMed ID: 14314907 [No Abstract] [Full Text] [Related]
11. RULES, REGULATIONS AND RESEARCH. NEIBEL OJ New Physician; 1963 Dec; 12():A85-A87. PubMed ID: 14103668 [No Abstract] [Full Text] [Related]
12. PROBLEMS IN DRUG DEVELOPMENT AS THEY RELATE TO THE PHARMACEUTICAL INDUSTRY. WINTER IC J New Drugs; 1964; 4(6):306-11. PubMed ID: 14247771 [No Abstract] [Full Text] [Related]
13. REGULATIONS AFFECTING DRUG RESEARCH AND DEVELOPMENT: A HISTORICAL PERSPECTIVE. KLUMPP TG J New Drugs; 1963; 3(4):212-20. PubMed ID: 14063357 [No Abstract] [Full Text] [Related]
14. THE IMPACT OF THE NEW FOOD AND DRUG LAWS AND REGULATIONS ON THE SPONSORS OF CLINICAL TRIALS. HEIN JW J Oral Ther Pharmacol; 1964 Jul; 1():85-92. PubMed ID: 14204420 [No Abstract] [Full Text] [Related]
15. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION. KELSEY FO J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363 [No Abstract] [Full Text] [Related]
16. PROBLEMS IN DRUG DEVELOPMENT AS THEY RELATE TO THE CLINICAL INVESTIGATOR. PFEIFFER CC J New Drugs; 1964; 4(6):299-305. PubMed ID: 14247770 [No Abstract] [Full Text] [Related]
17. [CONTROL OF AND EXPERIMENTATION WITH DRUGS]. MONNEROT-DUMAINE Presse Med (1893); 1963 Sep; 71():1786-8. PubMed ID: 14091591 [No Abstract] [Full Text] [Related]
18. NEW DRUG SURVEILLANCE IN 1964. ELLENHORN MJ J New Drugs; 1964; 4(3):166-75. PubMed ID: 14185008 [No Abstract] [Full Text] [Related]
19. The food and Drug Administration's view of investigational drugs. MEYERS EL SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340 [No Abstract] [Full Text] [Related]
20. THE RELATIONSHIP OF THE FOOD AND DRUG ADMINISTRATION TO THE PRACTICE OF MEDICINE AND THE AMINOPYRINE-DIPYRONE PROBLEM. SADUSK JF J New Drugs; 1965; 5(1):57-62. PubMed ID: 14283069 [No Abstract] [Full Text] [Related] [Next] [New Search]